• Search
  • Advanced Search

Review

January 5, 2023


Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, et al.
Clin Mol Hepatol. 2023;29(2):197-205.

Hepatocellular carcinoma (HCC) is a major cause of death in many countries, including South Korea. To provide useful and sensible advice for clinical management of patients with HCC, the Korean...

Review

December 22, 2022


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, et al.
Clin Mol Hepatol. 2023;29(2):206-216.

Liver cancer is the fourth most prevalent and the second most lethal cancer in China. Hepatitis B virus (HBV) infection represents a major risk factor for hepatocellular carcinoma (HCC). Liver...

Review

December 28, 2022


Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, et al.
Clin Mol Hepatol. 2023;29(2):217-229.

Hepatocellular carcinoma (HCC) is a major public health burden in Hong Kong, and chronic hepatitis B is the most common HCC etiology in our region. With the high case load,...

Review

January 30, 2023


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, et al.
Clin Mol Hepatol. 2023;29(2):230-241.
Hepatocellular carcinoma (HCC) is the fourth most common cancer and the second leading cause of cancer-related death in Taiwan. The Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan...

Review

March 20, 2023


Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, et al.
Clin Mol Hepatol. 2023;29(2):242-251.

Striking advances in systemic therapy for unresectable advanced hepatocellular carcinoma (HCC) have improved the average prognosis of patients with HCC. As a result, the guidelines for the treatment of HCC...

Review

March 10, 2023


Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(2):252-262.

Hepatocellular carcinoma (HCC) is highly prevalent and the third most common cause of cancer-related death in Asia. In contrast to the West, the main etiology of HCC in many Asian...

Review

January 19, 2023


The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, et al.
Clin Mol Hepatol. 2023;29(2):263-276.

Chronic hepatitis B infection is a major public health challenge. With the advancement in technology, various components of the viral cycle can now be measured in the blood to assess...

Review

January 30, 2023


Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, et al.
Clin Mol Hepatol. 2023;29(2):277-292.
Even though the combined use of ultrasound (US) and alpha-fetoprotein (AFP) is recommended for the surveillance of hepatocellular carcinoma (HCC), the utilization of AFP has its challenges, including accuracy dependent...

Review

February 1, 2023


Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, et al.
Clin Mol Hepatol. 2023;29(2):293-319.

Hepatocellular carcinoma (HCC) is one of the most common and deadly cancers worldwide and is characterized by complex molecular carcinogenesis. Neuropilins (NRPs) NRP1 and NRP2 are the receptors of multiple...

Review

February 1, 2023


Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.

The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known risk...

Original Article

November 21, 2022


Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, et al.
Clin Mol Hepatol. 2023;29(2):417-432.

Background/Aims: Immune and inflammatory cells respond to multiple pathological hits in the development of nonalcoholic steatohepatitis (NASH) and fibrosis. Relatively little is known about how their type and function change...

Original Article

January 4, 2023


Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990–2019: A DALY-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, et al.
Clin Mol Hepatol. 2023;29(2):433-452.

Background/Aims: Global distribution of dominant liver cancer aetiologies has significantly changed over the past decades. This study analyzed the updated temporal trends of liver cancer aetiologies and sociodemographic status in...

Original Article

February 1, 2023


Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
Yi-Te Lee, Mohammad A. Karim, Hye Chung Kum, et al.
Clin Mol Hepatol. 2023;29(2):453-464.

Background/Aims: Cirrhosis is the most important risk factor of hepatocellular carcinoma (HCC), and patients with cirrhosis are recommended to receive semiannual surveillance for early HCC detection. However, early cirrhosis is...

Original Article

February 20, 2023


Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions
Jing Yang, Xujiao Tang, Zhu Liang, et al.
Clin Mol Hepatol. 2023;29(2):465-481.

Background/Aims: Disrupted bile acid regulation and accumulation in the liver can contribute to progressive liver damage and fibrosis. However, the effects of bile acids on the activation of hepatic stellate...

Original Article

January 5, 2023


Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, et al.
Clin Mol Hepatol. 2023;29(2):482-495.

Background/Aims: The histologic status of the immune-tolerant (IT) phase of chronic hepatitis B relative to long-term outcomes is unclear. This study aimed to discover how the serological criteria currently in...

Original Article

March 6, 2023


Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, et al.
Clin Mol Hepatol. 2023;29(2):496-509.

Background/Aims: We used next-generation sequencing (NGS) to analyze resistance-associated substitutions (RASs) and retreatment outcomes in patients with chronic hepatitis C virus (HCV) infection who failed direct-acting antiviral agent (DAA) treatment...
Current Issue
Volume 29(2); Apr 2023

This archive contains links to the full-text of all issues of Clin Mol Hepatol.

Current issue

Volume 29(2); April

All issues

Vol. 29
2023

v.29(1)
Jan 2023

v.29(Suppl)
Feb 2023

v.29(2)
Apr 2023
Vol. 28
2022

v.28(1)
Jan 2022

v.28(2)
Apr 2022

v.28(3)
Jul 2022

v.28(4)
Oct 2022
Vol. 27
2021

v.27(1)
Jan 2021

v.27(2)
Apr 2021

v.27(3)
Jul 2021

v.27(4)
Oct 2021
Vol. 26
2020

v.26(1)
Jan 2020

v.26(2)
Apr 2020

v.26(3)
Jul 2020

v.26(4)
Oct 2020
Vol. 25
2019

v.25(1)
Mar 2019
v.25(2)
Jun 2019
v.25(3)
Sep 2019 		v.25(4)
Dec 2019
Vol. 24
2018

v.24(1)
Mar 2018
v.24(2)
Jun 2018
v.24(3)
Sep 2018
v.24(4)
Dec 2018
Vol. 23
2017

v.23(1)
Mar 2017
v.23(2)
Jun 2017
v.23(3)
Sep 2017
v.23(4)
Dec 2017
Vol. 22
2016

v.22(1)
Mar 2016
v.22(2)
Jun 2016
v.22(3)
Sep 2016
v.22(4)
Dec 2016
Vol. 21
2015

v.21(1)
Mar 2015
v.21(2)
Jun 2015
v.21(3)
Sep 2015
v.21(4)
Dec 2015
Vol. 20
2014

v.20(1)
Mar 2014
v.20(2)
Jun 2014
v.20(3)
Sep 2014
v.20(4)
Dec 2014
Vol. 19
2013

v.19(1)
Mar 2013
v.19(2)
Jun 2013
v.19(3)
Sep 2013
v.19(4)
Dec 2013
The Korean Journal of Hepatology1995 (Vol.1 No.1) to 2012 (Vol.18 No.1)
Vol. 18
2012

v.18(1)
Mar 2012
v.18(2)
Jun 2012
v.18(3)
Sep 2012
v.18(4)
Dec 2012
Vol. 17
2011
v.17(1)
Mar 2011 		v.17(2)
Jun 2011 		v.17(3)
Sep 2011 		v.17(4)
Dec 2011
Vol. 16
2010
v.16(1)
Mar 2010 		v.16(2)
Jun 2010 		v.16(3)
Sep 2010 		v.16(4)
Dec 2010
Vol. 15
2009
v.15(1)
Mar 2009 		v.15(2)
Jun 2009 		v.15(3)
Sep 2009 		v.15(4)
Dec 2009 		v.15(60)
Dec 2009
Vol. 14
2008
v.14(1)
Mar 2008 		v.14(2)
Jun 2008 		v.14(3)
Sep 2008 		v.14(4)
Dec 2008
Vol. 13
2007
v.13(1)
Mar 2007 		v.13(2)
Jun 2007 		v.13(3)
Sep 2007 		v.13(4)
Dec 2007
Vol. 12
2006
v.12(1)
Mar 2006 		v.12(2)
Jun 2006 		v.12(3)
Sep 2006 		v.12(4)
Dec 2006
Vol. 11
2005
v.11(1)
Mar 2005 		v.11(2)
Jun 2005 		v.11(3)
Sep 2005 		v.11(4)
Dec 2005
Vol. 10
2004
v.10(1)
Mar 2004 		v.10(2)
Jun 2004 		v.10(3)
Sep 2004 		v.10(4)
Dec 2004
Vol. 9
2003
v.9(1)
Mar 2003 		v.9(2)
Jun 2003 		v.9(3)
Sep 2003 		v.9(4)
Dec 2003
Vol. 8
2002
v.8(1)
Mar 2002 		v.8(2)
Jun 2002 		v.8(3)
Sep 2002 		v.8(4)
Dec 2002
Vol. 7
2001
v.7(1)
Mar 2001 		v.7(2)
Jun 2001 		v.7(3)
Sep 2001 		v.7(4)
Dec 2001
Vol. 6
2000
v.6(1)
Mar 2000 		v.6(2)
Jun 2000 		v.6(3)
Sep 2000 		v.6(4)
Dec 2000
Vol. 5
1999
v.5(1)
Mar 1999 		v.5(2)
Jun 1999 		v.5(3)
Sep 1999 		v.5(4)
Dec 1999
Vol. 4
1998
v.4(1)
Mar 1998 		v.4(2)
Jun 1998 		v.4(3)
Sep 1998 		v.4(4)
Dec 1998
Vol. 3
1997
v.3(1)
Mar 1997 		v.3(2)
Jun 1997 		v.3(3)
Sep 1997 		v.3(4)
Dec 1997
Vol. 2
1996
v.2(1)
Jun 1996 		v.2(2)
Dec 1996
Vol. 1
1995
v.1(1)
Jun 1995

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

ABOUT
BROWSE ARTICLES
CURRENT ISSUE
FOR CONTRIBUTORS
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 245
TOTAL : 1302079
Close layer